Aruni Ghose, CoFounder and Chief Medical Officer at OncoFlow, posted on LinkedIn:
“Cancer/Oncology Clinical Prediction and Prognostic Models for Personalising Treatment Selection and questioning Survival Benefit are a Mantra in Precision Oncology today.
Following the Huge Success of our “External Validation of the novel prognostic Meet-URO score in Metastatic Renal Cell Carcinoma on First Line (1L) Immune-Combination Therapy” with Sara Elena Rebuzzi. I am on the lookout for someone with evidenced and proven interest in Medical Statistics in Urological Oncology.
>10 Papers in the Pipeline and Good Authorship on these Landmark Articles. Are you interested? Please get in touch with me on direct message or Comment and I will get back.”